Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease
Published by Elsevier Inc..
The COVID-19 pandemic has resulted in significant morbidity and mortality worldwide. Management of the pandemic has relied mainly on SARS-CoV-2 vaccines, while alternative approaches such as meditation, shown to improve immunity, have been largely unexplored. Here, we probe the relationship between meditation and COVID-19 disease and directly test the impact of meditation on the induction of a blood environment that modulates viral infection. We found a significant inverse correlation between length of meditation practice and SARS-CoV-2 infection as well as accelerated resolution of symptomology of those infected. A meditation "dosing" effect was also observed. In cultured human lung cells, blood from experienced meditators induced factors that prevented entry of pseudotyped viruses for SARS-CoV-2 spike protein of both the wild-type Wuhan-1 virus and the Delta variant. We identified and validated SERPINA5, a serine protease inhibitor, as one possible protein factor in the blood of meditators that is necessary and sufficient for limiting pseudovirus entry into cells. In summary, we conclude that meditation can enhance resiliency to viral infection and may serve as a possible adjuvant therapy in the management of the COVID-19 pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Brain, behavior, & immunity - health - 32(2023) vom: 19. Okt., Seite 100675 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zuniga-Hertz, Juan P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adoptive blood transfer |
|---|
| Anmerkungen: |
Date Revised 20.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.bbih.2023.100675 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360993001 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360993001 | ||
| 003 | DE-627 | ||
| 005 | 20240420232144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bbih.2023.100675 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1381.xml |
| 035 | |a (DE-627)NLM360993001 | ||
| 035 | |a (NLM)37600600 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zuniga-Hertz, Juan P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 20.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Published by Elsevier Inc. | ||
| 520 | |a The COVID-19 pandemic has resulted in significant morbidity and mortality worldwide. Management of the pandemic has relied mainly on SARS-CoV-2 vaccines, while alternative approaches such as meditation, shown to improve immunity, have been largely unexplored. Here, we probe the relationship between meditation and COVID-19 disease and directly test the impact of meditation on the induction of a blood environment that modulates viral infection. We found a significant inverse correlation between length of meditation practice and SARS-CoV-2 infection as well as accelerated resolution of symptomology of those infected. A meditation "dosing" effect was also observed. In cultured human lung cells, blood from experienced meditators induced factors that prevented entry of pseudotyped viruses for SARS-CoV-2 spike protein of both the wild-type Wuhan-1 virus and the Delta variant. We identified and validated SERPINA5, a serine protease inhibitor, as one possible protein factor in the blood of meditators that is necessary and sufficient for limiting pseudovirus entry into cells. In summary, we conclude that meditation can enhance resiliency to viral infection and may serve as a possible adjuvant therapy in the management of the COVID-19 pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Adoptive blood transfer | |
| 650 | 4 | |a COVID-19 disease | |
| 650 | 4 | |a Immunity | |
| 650 | 4 | |a Meditation | |
| 650 | 4 | |a Pseudovirus | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a serpin | |
| 700 | 1 | |a Chitteti, Ramamurthy |e verfasserin |4 aut | |
| 700 | 1 | |a Dispenza, Joe |e verfasserin |4 aut | |
| 700 | 1 | |a Cuomo, Raphael |e verfasserin |4 aut | |
| 700 | 1 | |a Bonds, Jacqueline A |e verfasserin |4 aut | |
| 700 | 1 | |a Kopp, Elena L |e verfasserin |4 aut | |
| 700 | 1 | |a Simpson, Sierra |e verfasserin |4 aut | |
| 700 | 1 | |a Okerblom, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Maurya, Svetlana |e verfasserin |4 aut | |
| 700 | 1 | |a Rana, Brinda K |e verfasserin |4 aut | |
| 700 | 1 | |a Miyonahara, Atsushi |e verfasserin |4 aut | |
| 700 | 1 | |a Niesman, Ingrid R |e verfasserin |4 aut | |
| 700 | 1 | |a Maree, Jacqueline |e verfasserin |4 aut | |
| 700 | 1 | |a Belza, Gianna |e verfasserin |4 aut | |
| 700 | 1 | |a Hamilton, Hillari D |e verfasserin |4 aut | |
| 700 | 1 | |a Stanton, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Gonzalez, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Poirier, Michelle A |e verfasserin |4 aut | |
| 700 | 1 | |a Moeller-Bertram, Tobias |e verfasserin |4 aut | |
| 700 | 1 | |a Patel, Hemal H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Brain, behavior, & immunity - health |d 2020 |g 32(2023) vom: 19. Okt., Seite 100675 |w (DE-627)NLM307291391 |x 2666-3546 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2023 |g day:19 |g month:10 |g pages:100675 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bbih.2023.100675 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2023 |b 19 |c 10 |h 100675 | ||